HLHS Subtypes #3 – MA/AA (Mitral Atresia / Aortic Atresia)

Date
November 23, 2025
URL
https://x.com/WithAScalpel/status/1992561120532369630?s=20
Categories
HLHS

HLHS Subtypes – Mitral Atresia / Aortic Atresia (MA/AA)

image

The mitral atresia / aortic atresia (MA/AA) subtype occupies the most extreme end of the HLHS spectrum. Both inflow and outflow valves of the left ventricle are atretic, the ascending aorta and arch are severely hypoplastic, and the left ventricle is diminutive or essentially absent, often seen only as a slit-like remnant along the posterior wall.[1] In this setting, there is no recruitable left-sided pump and no valve-mediated connection between the pulmonary venous circulation and the systemic arterial tree.

As a result, all effective systemic output is generated by the right ventricle (RV) and delivered through the ductus arteriosus, and survival depends on a sufficiently large atrial-level communication to decompress pulmonary venous return.[2]

1. Anatomic Features

  1. Left ventricle (LV)
    • The LV is rudimentary or absent:
      • Often a thin, slit-like or flattened cavity adherent to the posterior ventricular wall.
      • Functionally incapable of contributing to forward flow.
    • Because there is virtually no inflow or outflow loading in fetal life, the LV myocardium is usually hypoplastic but not massively hypertrophied or fibroelastotic, in contrast to the thick, EFE-lined ventricles seen in MS/AA.[1]
  2. Mitral valve – Mitral atresia
    • There is no patent connection between the left atrium (LA) and LV.
    • The mitral orifice is replaced by a fibrous plate or fused leaflet mass; chordae and papillary muscles are rudimentary or absent.
    • All pulmonary venous return must exit the LA via an atrial septal communication.
  3. Aortic valve and ascending aorta – Aortic atresia
    • The aortic valve is completely atretic; there is no LV–aorta continuity.
    • The ascending aorta and arch are among the smallest in HLHS, usually thread-like segments perfused only by retrograde flow from the ductus arteriosus.[1]
    • Coronary arteries arise from this diminutive ascending aorta and depend entirely on retrograde perfusion rather than LV ejection.
  4. Atrial septum
    • A generous atrial septal defect (ASD) or large patent foramen ovale (PFO) is essential for pulmonary venous decompression.
    • MA/AA is strongly associated with an intact or highly restrictive atrial septum, which is a major determinant of perinatal stability and later neurodevelopment.[2]
  5. Right ventricle and great vessels
    • The RV is the sole functional ventricle and ultimately serves as the systemic pump.
    • Systemic and coronary circulation are supplied by:
      • RV → main pulmonary artery → patent ductus arteriosus (PDA) → descending aorta → retrograde flow into the arch, ascending aorta, and coronaries.

2. Hemodynamics and Pathophysiology

  1. Complete ductal dependence for systemic output
    • Because both mitral and aortic valves are atretic, there is no antegrade LV output.
    • All systemic flow is RV-derived and reaches the body through the PDA with retrograde perfusion of the arch and ascending aorta.
    • Any ductal constriction results in rapid systemic hypotension, impaired coronary perfusion, and shock.
  2. Pulmonary venous hypertension driven by atrial-level obstruction
    • Pulmonary venous blood enters the LA but cannot leave through a mitral valve.
    • When the atrial septum is intact or restrictive, LA and pulmonary venous pressures rise dramatically, producing:
      • Severe pulmonary edema and hypoxemia,
      • Profound acidosis and hemodynamic collapse in the immediate neonatal period,
      • Risk of in utero and early postnatal pulmonary vascular remodeling with adverse neurologic outcome.[2]
    • Thus, atrial-level obstruction is often the immediate life-threatening lesion in MA/AA.
  3. Coronary perfusion
    • Coronaries fill retrogradely from ductal flow entering the diminutive ascending aorta.
    • Adequate diastolic aortic pressure and ductal patency are therefore critical for RV myocardial perfusion.
    • Unlike MS/AA, MA/AA hearts rarely exhibit extensive ventriculocoronary connections; sinusoidal LV–coronary fistulas and ischemia related to LV decompression are characteristically problems of the MS/AA subtype rather than MA/AA.[1]

Overall, MA/AA combines absolute dependence on ductal and atrial-level patency with the absence of a salvageable LV, making it the archetypal single-ventricle lesion.

3. Clinical Profile, Outcomes, and Risk Features

3.1 Presentation

Most infants with MA/AA present as critically ill neonates:

  • Immediately after birth
    • Cyanosis and respiratory distress from pulmonary venous hypertension if the atrial septum is restrictive.
    • Rapid deterioration as the ductus constricts, with systemic hypoperfusion, metabolic acidosis, and myocardial ischemia.

3.2 Outcome by anatomic subtype

The prognostic impact of MA/AA must be interpreted in the context of other HLHS variants:

  • In a Norwood cohort stratified by anatomic subtype, long-term survival after Norwood was 60% for AA–MA (MA/AA), 65% for AS–MS, and only 26% for AA–MS (MS/AA), highlighting that the worst long-term Norwood survival is concentrated in the MS/AA group rather than MA/AA.[3]
  • Among Fontan survivors, Moon and colleagues found transplant-free survival at 17 years of 74.6% for AA/MA, 79.1% for AS/MS, and 56.1% for AA/MS, again confirming that AA/MS carries the greatest long-term risk, whereas AA/MA shows intermediate but not prohibitive survival.[4]
  • Across unselected HLHS populations, contemporary series report overall survival into adolescence approaching 60–70%, with intact/restrictive atrial septum, low birth weight, genetic syndromes, and aortic atresia variants among the strongest early risk factors.[2]

Thus, although MA/AA is anatomically the most extreme lesion, its late survival after successful palliation is not necessarily worse than all other subtypes. Early outcome is dominated by atrial septal physiology and surgical complexity, while late outcome reflects RV function and Fontan physiology, similar to other HLHS variants.

3.3 Key risk modifiers in MA/AA

  • Atrial septal restriction
    • Strongly associated with early mortality and adverse neurodevelopment due to prolonged pulmonary venous hypertension and low cerebral oxygen delivery.[2]
  • Ascending aorta and arch size
    • The extremely hypoplastic ascending aorta and arch increase the technical difficulty of Norwood reconstruction and magnify the consequences of any ductal compromise.[1]
  • Systemic RV performance
    • As in all HLHS variants, long-term prognosis after Fontan depends heavily on RV systolic and diastolic function, tricuspid valve competence, and Fontan pathway integrity.[2,4]

4. Surgical Strategy

Because the LV is non-functional and cannot be recruited, MA/AA is unambiguously committed to a single-ventricle pathway. Management focuses on:

  1. Stabilizing ductal and atrial-level patency in the neonatal period.
  2. Establishing a reliable systemic circulation powered by the RV.
  3. Progressing through Glenn and Fontan while preserving RV and Fontan pathway function.[2]

4.1 Immediate neonatal management

  1. Maintain ductal patency
    • Initiate prostaglandin E₁ (PGE₁) infusion promptly to prevent ductal constriction and maintain systemic and coronary perfusion.
  2. Relieve atrial septal obstruction when present
    • Indications include:
      • Severe hypoxemia with high pulmonary venous pressures,
      • Marked right-to-left atrial gradient on echocardiography,
      • Refractory acidosis or hemodynamic instability.
    • Techniques:
      • Balloon atrial septostomy,
      • Static balloon dilation of the atrial septum,
      • Stent placement or surgical septectomy, depending on anatomy and institutional expertise.
  3. Balance pulmonary and systemic blood flow
    • Avoid excessive pulmonary blood flow that can steal from systemic and coronary circulation, while maintaining adequate oxygenation.
    • Support systemic blood pressure to preserve retrograde coronary perfusion.

4.2 Norwood Stage I and subsequent palliation

  1. Norwood Stage I
    • Construction of a neo-aorta from the pulmonary root and hypoplastic ascending aorta, with extensive arch augmentation.
    • Provision of controlled pulmonary blood flow via a modified Blalock–Taussig shunt or RV–pulmonary artery conduit.
    • Ensuring a wide atrial communication (if not already created) to prevent recurrent pulmonary venous hypertension.
  2. Bidirectional Glenn and Fontan completion
    • Bidirectional Glenn unloads the RV by directing superior vena caval blood directly into the pulmonary arteries.
    • Fontan completion establishes total cavopulmonary connection, leaving the RV as the sole systemic ventricle.
    • Long-term follow-up concentrates on systemic RV function, tricuspid valve regurgitation, arrhythmias, and Fontan-related complications.[2,4]

5. Teaching Pearls for MA/AA

  • “Pure single-ventricle” anatomy

    • MA/AA is the quintessential HLHS variant with no realistic route to biventricular repair: there is no inflow or outflow from the LV, which is rudimentary or absent.[1]

  • Two acute threats at birth: ductal closure and atrial restriction

      • Early management must prioritize:

    1. Maintaining ductal patency to preserve systemic and coronary perfusion.
    2. Rapid identification and relief of atrial septal restriction to prevent catastrophic pulmonary venous hypertension and neurologic injury.[2]
  • Ascending aorta size as a surrogate for operative complexity

    • The extremely hypoplastic ascending aorta and arch make arch reconstruction technically demanding, and precise Norwood execution is crucial for durable RV and coronary perfusion.[1,3]

  • Comparison with other subtypes

    • While MA/AA is the most extreme anatomically, contemporary data show that the poorest long-term survival and highest burden of ventricular failure are concentrated in AA/MS (MS/AA), likely due to chronic LV pressure overload and ventriculocoronary connections in that subtype.[3,4] Recognizing these distinctions helps frame prognosis and counseling.

  • Conceptual takeaway
    • When you see MA/AA, think:

    “Absent LV, thread-like aorta, RV-via-ductus systemic output, and the atrial septum as the gatekeeper of pulmonary venous return.”

    This mental model clarifies the priorities for emergent intervention and the rationale for a staged single-ventricle strategy.

References

[1] Crucean A, Ramsbottom SA, Henderson DJ, Chaudhry B. Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective. Orphanet J Rare Dis. 2017;12:138.

[2] Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM, Mahle WT, et al. Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol. 2012;59(1 Suppl):S1-42.

[3] Shuhaiber J, Morgan B, Gottliebson W. Survival outcomes following Norwood procedure for hypoplastic left heart. Pediatr Cardiol. 2015;36(1):57-63.

[4] Moon J, Lancaster T, Sood V, Si MS, Ohye RG, Romano JC. Long-term impact of anatomic subtype in hypoplastic left heart syndrome after Fontan completion. J Thorac Cardiovasc Surg. 2024;168(1):193-201.e3.